Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Poster Exhibition<br />
Poster view with present<strong>in</strong>g authors on Friday, March 16, 6:30 – 8:00 p.m.<br />
P1<br />
Genome Eng<strong>in</strong>eer<strong>in</strong>g <strong>and</strong> Repair<br />
P1.01 Extr<strong>in</strong>sic determ<strong>in</strong>ants of ZFN <strong>and</strong> TALEN-mediated gene disruption<br />
Nad<strong>in</strong>e Dannemann, Hannover<br />
P1.02 pEPI comes of age - Improvement of a non-viral, episomal vector<br />
Claudia Hagedorn, Witten<br />
P1.03 The Evolution of a dose controlled Retroviral Prote<strong>in</strong> Transfer<br />
System<br />
Tobias Maetzig, Hannover<br />
P1.04 Development of a site directed gene therapy approach by exploit<strong>in</strong>g<br />
the HPRT locus <strong>in</strong> hematopoietic progenitor cells<br />
Frank Schnütgen, Frankfurt<br />
P1.05 <strong>Gene</strong>tic Correction of the Human ∆F508 CFTR Locus Us<strong>in</strong>g<br />
the Z<strong>in</strong>c-F<strong>in</strong>ger Nuclease Technology<br />
Christien Bednarski, Hannover<br />
P1.06 Novel methods of z<strong>in</strong>c f<strong>in</strong>ger nuclease delivery to cells<br />
Sylwia Bobis-Wozowicz, Hannover<br />
P1.07 Adeno-Associated Virus Vectors Mediated Targeted Genome Edit<strong>in</strong>g<br />
By Z<strong>in</strong>c F<strong>in</strong>ger Nucleases<br />
Kafaitullah Khan, Hannover<br />
P1.08 M<strong>in</strong>icircle DNA – from construction to performance test<strong>in</strong>g<br />
Marco Schmeer, Bielefeld<br />
P1.09 Copper-mediated selection of transduced cells by human copper<br />
transporter ATP7B<br />
Nad<strong>in</strong>e Schmitt, Münster<br />
P1.10 Non-viral <strong>Gene</strong> Delivery by Sleep<strong>in</strong>g Beauty Transposon Vectors for<br />
<strong>Gene</strong> Therapy of Gaucher Disease<br />
Marta Swierczek, Langen<br />
P1.11 Comparative analysis of ZFNs <strong>and</strong> TALENs target<strong>in</strong>g the<br />
X-SCID-associated IL2RG locus<br />
Jamal AlZu’bi, Hannover<br />
P 2a<br />
P2a.01<br />
P2a.02<br />
iPS, Reprogramm<strong>in</strong>g <strong>and</strong> Hematopoiesis<br />
Patterns Of HERV-K Expression In Malignant And Non-Malignant<br />
Pluripotent Stem <strong>Cell</strong>s<br />
N<strong>in</strong>a Fuchs, Berl<strong>in</strong><br />
CXCL9 <strong>and</strong> IL32 regulate HSC expansion <strong>and</strong> protect hematopoietic<br />
progenitor cells from chemotherapy<br />
Anja Moldenhauer, Ludwigshafen<br />
27
Change language